Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,143 | -2,100 | 4,945 | 5,513 | 2,347 |
| Depreciation Amortization | 12,537 | 6,176 | 23,449 | 17,118 | 11,274 |
| Income taxes - deferred | -5,689 | N/A | 2,012 | N/A | N/A |
| Accounts receivable | -25,978 | -15,117 | 5,539 | -1,761 | -4,970 |
| Accounts payable and accrued liabilities | -2,147 | -4,391 | -108 | -3,661 | -3,535 |
| Other Working Capital | -28,262 | -20,702 | -18,073 | -15,421 | -18,444 |
| Other Operating Activity | 63,258 | 25,972 | 13,153 | 18,515 | 16,897 |
| Operating Cash Flow | $-5,424 | $-10,162 | $30,917 | $20,303 | $3,569 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,102 | -2,222 | -24,364 | -21,040 | -15,061 |
| Investing Cash Flow | $-4,102 | $-2,222 | $-24,364 | $-21,040 | $-15,061 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,341 | -1,668 | -5,173 | -3,395 | -1,958 |
| Common Stock Issued | 180 | 180 | N/A | N/A | N/A |
| Other Financing Activity | -1,174 | -1,120 | -332 | -333 | -332 |
| Financing Cash Flow | $-4,335 | $-2,608 | $-5,505 | $-3,728 | $-2,290 |
| Beginning Cash Position | 104,338 | 104,338 | 103,290 | 103,290 | 103,290 |
| End Cash Position | 90,477 | 89,346 | 104,338 | 98,825 | 89,508 |
| Net Cash Flow | $-13,861 | $-14,992 | $1,048 | $-4,465 | $-13,782 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,424 | -10,162 | 30,917 | 20,303 | 3,569 |
| Capital Expenditure | -4,102 | -2,222 | -24,364 | -21,040 | -15,061 |
| Free Cash Flow | -9,526 | -12,384 | 6,553 | -737 | -11,492 |